For rapid detection of SARS-CoV-2
Our Q-POC™ SARS-CoV-2 Assay has been developed using advanced bioinformatics to maximise performance.
The assay has been designed with the most up-to-data sequence information to ensure 100% inclusivity of all known SARS-CoV-2 sequences.
Key features & benefits:
- ACCESSIBLE – mid-nasal swab for enhanced patient comfort
- SPECIFIC – 100% coverage of all known strains and sequences
- SENSITIVE – No ‘indeterminate’ result
- BUILT-IN QA – targeting three loci – S gene, N gene, Orf1 region
- EXCLUSIVITY – No cross-reactivity or interference due to common commensal organisms
- SAFE – Sealed, single use test cassette designed to reduce contamination risk and ensure accurate readings for optimal patient care.
- CONVENIENT – On-board reagents are lyophilised for room temperature storage, ease of shipping and a longer shelf life